Skip to main content Skip to footer
American Family Children's Hospital
SHARE TEXT
 


Print Friendly Page

Protocol No. UW18001

Principal Investigator Kim, Peggy

Phase I

Age Group Adult

Scope National

Sponsor Type Industry

Title A Multicenter, Open Label, Phase 1b Study to Assess the Safety and Define the Maximally Tolerated Dose of Epidural Resiniferatoxin Injection for the Treatment of Intractable Pain Associated with Cancer

Applicable Disease Sites Anal; Bladder; Brain/Central Nervous System; Cervix; Colon and Rectum; Endocrine cancers; Gastrointestinal cancers, other; Genitourinary cancers, other; Hematologic cancers, other; Kidney; Leukemia; Liver; Lung; Lymphoma; Melanoma/Skin cancer; Multiple Myeloma; Ovary; Pancreas; Prostate; Sarcoma; Stomach; Uterus

Drugs Involved RTX (Resiniferatoxin); Resiniferatoxin

Status Open

Participating Institutions UW Hospital and Clinics